277
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents

, , , , &
Pages 1015-1026 | Published online: 30 Jul 2018

References

  • Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–241.
  • Suetens C, Hopkins S, Kolman J, Diaz Högberg L. Point Prevalence Survey of Healthcare Associated Infections And Antimicrobial Use in European Acute Care Hospitals. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2013.
  • Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. 2007;65(Suppl 2):50–54.
  • Mitchell BG, Dancer SJ, Anderson M, Dehn E. Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis. J Hosp Infect. 2015;91(3):211–217.
  • Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis. 2004;39(8):1182–1189.
  • Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev. 2014;27(4):665–690.
  • Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol. 2011;32(7):687–699.
  • Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect. 2009;73(4):378–385.
  • Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis. 2013;26(4):338–344.
  • Weber DJ, Rutala WA. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 1997;18(5):306–309.
  • Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010;38(5 Suppl 1):S25–S33.
  • Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130.
  • DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 2009;119(9):2464–2474.
  • Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(Suppl 2):S114–S132.
  • McDougal LK, Fosheim GE, Nicholson A, et al. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob Agents Chemother. 2010;54(9):3804–3811.
  • Jamal M, Hussain T, Rajanna Das C, Andleeb S. Isolation and characterization of a myoviridae MJ1 bacteriophage against multi-drug resistant Escherichia coli 3. Jundishapur J Microbiol. 2015;8(11):e25917.
  • Thaden JT, Park LP, Maskarinec SA, Ruffin F, Fowler VG Jr, van Duin D. Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by pseudomonas aeruginosa compared to other bacteria. Antimicrob Agents Chemother. 2017;61(6):e02671-16.
  • Palacios-Baena ZR, Gutierrez-Gutierrez B, De Cueto M, et al. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother. 2017;72(3):906–913.
  • WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017. Available from: http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. Accessed April 4, 2018.
  • Bock LJ, Wand ME, Sutton JM. Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains. J Hosp Infect. 2016;93(1):42–48.
  • Wand ME, Bock LJ, Bonney LC, Sutton JM. Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother. 2017;61(1):e01162-16.
  • Cornejo-Juarez P, Vilar-Compte D, Perez-Jimenez C, Namendys-Silva SA, Sandoval-Hernandez S, Volkow-Fernandez P. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis. 2015;31:31–34.
  • Caini S, Hajdu A, Kurcz A, Borocz K. Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010. Euro Surveill. 2013;18(2):20352.
  • WHO. Antimicrobial Resistance: Global Report on Surveillance, 2014. 2014. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed April 04, 2018.
  • Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006;166(18):1945–1951.
  • Drees M, Snydman DR, Schmid CH, et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis. 2008;46(5):678–685.
  • Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect. 2011;17(8):1201–1208.
  • Caselli E, D’Accolti M, Vandini A, et al. Impact of a probiotic-based cleaning intervention on the microbiota ecosystem of the hospital surfaces: focus on the resistome remodulation. PLoS One. 2016;11(2): e0148857.
  • Vandini A, Temmerman R, Frabetti A, et al. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One. 2014;9(9):e108598.
  • Caselli E. Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings. Microb Biotechnol. 2017;10(5):1079–1083.
  • Caselli E, Antonioli P, Mazzacane S. Safety of probiotics used for hospital environmental sanitation. J Hosp Infect. 2016;94(2):193–194.
  • Abuladze T, Li M, Menetrez MY, Dean T, Senecal A, Sulakvelidze A. Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. Appl Environ Microbiol. 2008;74(20):6230–6238.
  • Greer GG. Bacteriophage control of foodborne bacteriat. J Food Prot. 2005;68(5):1102–1111.
  • Tomat D, Quiberoni A, Mercanti D, Balague C. Hard surfaces decontamination of enteropathogenic and Shiga toxin-producing Escherichia coli using bacteriophages. Food Res Int. 2014;57:123–129.
  • Sulakvelidze A. Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. Drug Discov Today. 2005;10(12):807–809.
  • Jensen KC, Hair BB, Wienclaw TM, et al. Isolation and host range of bacteriophage with lytic activity against methicillin-resistant Staphylococcus aureus and potential use as a fomite decontaminant. PLoS One. 2015;10(7):e0131714.
  • Regulations C-CoF. Title 21: Food and drugs. Chapter 1: Food and Drug Administration; Department of Health and Human Services. Subchaper B: Food for human consumption. PART 172: Food additives permitted for direct addition to food for human consumption. Subpart H: Other Specific Usage Additives. Sec. 172.785 Listeria-specific bacteriophage preparation. 2017. Available from: https://www.gpo.gov/fdsys/pkg/CFR-2011-title21-vol3/pdf/CFR-2011-title21-vol3-chapI.pdf. Accessed April 04, 2018.
  • EUCAST. The European Committee on Antimicrobial Susceptibility Testing – EUCAST. October 20, 2017. Available from: http://www.eucast.org/. Accessed July 12, 2018.
  • CLSI. Performance standards for antimicrobial susceptibility testing. 28th edition. 2018. Available from: https://clsi.org/standards/products/microbiology/documents/m100/. Accessed July 12, 2018.
  • Caselli E. Testing antibacterial activity of bacteriophages on hard surfaces. http://www.protocols.io. 2018; Available from: dx.doi.org/10.17504/protocols.io.nwmdfc6. Accessed July 12, 2018.
  • Ho YH, Tseng CC, Wang LS, et al. Application of bacteriophage-containing aerosol against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii in an intensive care unit. PLoS One. 2016;11(12):e0168380.